Skip to content

Jay S Stout, Chief Technology Officer at Immunovant, sold IMVT on Oct 7, 2026

Data as of Oct 16

▼ SELL$70.9K2,213 shares at $32.06Jay S Stout Chief Technology OfficerIMVT Immunovant, Inc.
Watch IMVT
Traded
Oct 7, 2026
Disclosed
Oct 9, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Jay S Stout, Chief Technology Officer at Immunovant, sold IMVT on Oct 7, 2026TRADEDDISCLOSED
IMVTSimilar stocks (XLV — its sector index fund), rebased to IMVT's price on the disclosure day
IMVT since disclosure
−12.3%
after the sale
Similar stocks (XLV) since disclosure
+3.5%
XLV — its sector index fund

Change in closing price from Oct 9, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLJay S Stout Chief Technology OfficerIMVT Immunovant, Inc.$51.2Kdisclosed Oct 9 · filed 2 days after the trade

See every trade on IMVT →